| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42.9M | +31.7% | +56.6% |
| Cost of Revenue | $21.5M | +32.0% | +86.5% |
| Gross Profit | $21.3M | +31.4% | +34.8% |
| R&D Expense | $5.6M | +18.4% | -3.5% |
| SG&A Expense | $12.6M | -27.0% | -10.0% |
| Operating Income | -$8.6M | +50.9% | +55.1% |
| Pre-tax Income | -$1.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.5M | -14.7% | -31.6% |
| Short-term Investments | $24.7M | — | +148.2% |
| Accounts Receivable | $48.9M | +16.9% | +40.2% |
| Inventory | $8.8M | -27.8% | -46.1% |
| Current Assets | $151.6M | +13.9% | +12.8% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.1M | — | — |
| Investing Cash Flow | -$43.2M | — | — |
| Financing Cash Flow | $34.7M | — | — |
| +95.6% |
| +94.1% |
| Income Tax | $0 | +100.0% | — |
| Net Income | -$1.8M | +95.6% | +94.1% |
| EPS (Basic) | -$0.01 | +96.0% | +94.7% |
| EPS (Diluted) | -$0.01 | +96.0% | +94.7% |
| $304.3M |
| +8.5% |
| +9.3% |
| Current Liabilities | $119.3M | -16.5% | +33.4% |
| Long-term Debt | $28.5M | — | — |
| Total Liabilities | $202.1M | +7.6% | +35.2% |
| Stockholders' Equity | $102.2M | +10.3% | -20.7% |